Neonc Technologies (NASDAQ:NTHI) Stock: Insider Amir Heshmatpour Buys 10,000 Shares

Neonc Technologies Holdings, Inc. (NASDAQ:NTHI) CEO Amir Heshmatpour acquired 10,000 shares of Neonc Technologies stock in a transaction that occurred on Monday, November 9th. The shares were purchased at an average price of $3.86 per share, for a total transaction of $38,600.00. Following the transaction, the chief executive officer directly owned 3,263,000 shares in the company, valued at $12,595,180. The trade was a 0.31% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available through this hyperlink.

Neonc Technologies Trading Up 16.8%

Neonc Technologies stock opened at $4.37 on Wednesday. The stock has a 50-day moving average price of $3.30 and a two-hundred day moving average price of $5.34. Neonc Technologies Holdings, Inc. has a 12 month low of $2.50 and a 12 month high of $12.00.

Neonc Technologies (NASDAQ:NTHI) last posted its earnings results on Thursday, November 5th. The company reported ($0.28) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.25) by ($0.03).

Wall Street Analyst Weigh In

A number of equities research analysts have commented on NTHI shares. BTIG Research reiterated a “buy” rating and issued a $15.00 price target on shares of Neonc Technologies in a research report on Tuesday, September 8th. Weiss Ratings cut Neonc Technologies from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Wednesday, October 21st. Wall Street Zen upgraded Neonc Technologies from a “sell” rating to a “hold” rating in a research report on Saturday. Roth Capital began coverage on Neonc Technologies in a research note on Thursday, September 24th. They issued a “buy” rating on the stock. Finally, Zacks Research raised Neonc Technologies from a “strong sell” rating to a “hold” rating in a research note on Thursday, November 5th. Four investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $16.00.

Institutional Trading of Neonc Technologies

A number of large investors have recently bought and sold shares of the business. Bank of America Corp DE boosted its position in shares of Neonc Technologies by 5.0% during the 1st quarter. Bank of America Corp DE now owns 235,396 shares of the company’s stock valued at $1,650,000 after purchasing an additional 11,108 shares in the last quarter. Global Retirement Partners LLC acquired a new position in shares of Neonc Technologies during the 2nd quarter valued at $126,000. Westmount Partners LLC boosted its stake in Neonc Technologies by 355.2% during the second quarter. Westmount Partners LLC now owns 197,178 shares of the company’s stock worth $893,000 after acquiring an additional 153,858 shares in the last quarter. Finally, BlackRock Inc. bought a new position in Neonc Technologies during the second quarter worth $815,000.

Neonc Technologies Company Profile

NeOnc Technologies Holdings, Inc. is a biotechnology company developing treatments for brain tumors and other central nervous system cancers. Its research focuses on approaches intended to deliver therapies to the brain, where the blood-brain barrier can limit the effectiveness of conventional treatments. The company’s pipeline includes NEO100, a formulation of perillyl alcohol designed for intranasal delivery, and NEO212, a compound combining perillyl alcohol with temozolomide. These candidates are being developed for potential use in brain cancer treatment.